Home
Finance
Companies
Industry
Market

ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc [SPRY] Revenue clocked in at $112.34 million, down -29.54% YTD: What’s Next?

October 2, 2025

Misty Lee

ARS Pharmaceuticals Inc [NASDAQ: SPRY] surged by $0.04 during the normal trading session on Wednesday and reaching a high of ...

most recent

Companies

Jefferies slashes price target on VisionSys AI Inc ADR [VSA] – find out why.

Market

H.C. Wainwright lifts American Bitcoin Corp [ABTC] price estimate. Who else is bullish?

Finance

Market cap of Vistra Corp [VST] reaches 68.28B – now what?

Industry

Enphase Energy Inc [ENPH] stock Upgrade by Jefferies analyst, price target now $36

Companies

Wall Street Analyst Initiated James Hardie Industries plc [JHX]. What else is Wall St. saying

Finance

Elanco Animal Health Inc [ELAN] is 45.25% higher this YTD. Is it still time to buy?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled